ECCT Joint Retail & Distribution, Pharmaceutical, Medical Device, Cosmetics and Healthcare Enhancement Committees Lunch- Lunch with the TFDA Director-General 衛福部食品藥物管理署 吳秀梅 署長
ECCT Joint Retail & Distribution, Pharmaceutical, Medical Device, Cosmetics and Healthcare Enhancement Committees Lunch- Lunch with TFDA Director - General
Vision and future direction of food and pharmaceutical management
Dr. Wu Shou-mei, Director-General, Food & Drug Administration, Ministry of Health & Welfare (MOHW) 衛福部食品藥物管理署 吳秀梅 署長
12:00 – 14:00, Tuesday, 9 January 2018
Mandarin Oriental, Taipei, B2F Mandarin Ballroom II / 文華東方酒店 文華廳 貳
No. 158 Dunhua North Road, Taipei / 台北市敦化北路 158 號
Taiwan continues its move towards adopting international standards and it is a stated objective of Taiwan's Food & Drug Administration (TFDA) to "establish an internationalized regulatory system for food, drugs, medical devices andcosmetics". At this event, jointly hosted by the ECCT's Retail & Distribution and Pharmaceutical committees, our guest speaker will outline the TFDA's vision and future policy direction towards reaching its objectives.
In 2017 the TFDA announced draft regulations regarding market access for beef from The Netherlands and Sweden while the Council of Agriculture simplified theorganiclabelling permit application process for importing organic products, thereby giving consumers in Taiwan a wider variety of healthy, affordable and high-quality food products. However, in the fields of food and drug controls, there remain instances where Taiwan's standards and procedures deviate from established international norms.
In terms of food, even though the European Union (EU) is a major producerofhigh quality food products, food-related exports from the EU to Taiwan remain relatively low, accounting for just 13% of Taiwan's food imports. This indicates that there is room to improve Taiwan's complex approval and inspection procedures.
In terms of pharmaceuticals, by world standards, Taiwanese patients experience significant delays in getting access to new life-changing medicines, and there are several procedural barriers that can be improved to further accelerate patients' access to new treatment.
At this special event, officials from different divisions under TFDA will accompany Director-General Wu to interact with members. This will present a great opportunity for members to engage in dialogue with officials from the TFDA, exchange ideas and discuss future projects and potential areas of cooperation between the ECCT and the TFDA.
About the speaker
Dr. Wu Shou-mei 吳秀梅is the Director-General of the Food & Drug Administration (TFDA) under the Ministry of Health & Welfare (MOHW). She has had a distinguished academic career with posts both in Taiwan and overseas. At Kaohsiung Medical University she was previously Professor of the School of Pharmacy, Director of the Department of Fragrance and Cosmetic Science and Dean of the College of Pharmacy. She has also been a visiting fellow at the School of Chemistry, University of Virginia in the United States and the School of Pharmacy at Tokushima University in Japan. She holds a PhD in pharmaceutical analysis from Kaohsiung Medical University.
NT$1,600 for members; NT$2,200 for members' guest(s)